Cyclodextrin-based materials for pulmonary delivery: Insights and challenges
The literature provides a large range of information on the manufacturing of CD-based materials for pulmonary delivery, the characterization of
Tag: pulmonary delivery
Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections
The goal of this research initiative was to explore the utilization of a microparticle antibiotic delivery system, which could provide
Inhalation drug delivery in combating pulmonary infections
Pulmonary infections (PIs) are contributing as a significant cause of mortality across the world. The clinical applications of a variety
Supercritical antisolvent process for the preparation of inhalable quercetin-β-cyclodextrin inclusion complexes
In this study, Que-β-cyclodextrin inclusion complexes (Que-β-CD) were prepared using the supercritical antisolvent (SAS) process with supercritical carbon dioxide (SCCO2)
Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Remdesivir, an investigational broad-spectrum antiviral agent, formulated with sulfobutyl beta-cyclodextrin, has shown in vitro activity against SARSCoV-2. Currently, remdesivir is
Inhaled Interferons to treat COVID-19
Why interferons? SARS CoV viruses block interferon production in infected cells, allowing the virus to continue replicating unabated. Treatment with interferons